Brooks to Participate in the KeyBanc Life Sciences & MedTech Investor Forum
News provided by
Share this article
Share this article
CHELMSFORD, Mass., March 15, 2021 /PRNewswire/ Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021 which includes a 35-minute webcast beginning at 1:15 p.m. ET. The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. A replay of the webcast will be available following the event.
About Brooks Automation
Brooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company s Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the i
Brooks Automation Announces Fiscal 2021 First Quarter Earnings Conference Call and Webcast
News provided by
Share this article
Share this article
CHELMSFORD, Mass., Jan. 26, 2021 /PRNewswire/ Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 first quarter which ended on December 31, 2020 on Tuesday, February 2, 2021 after the market closes.
The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, February 2, 2021 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-734-8583 for domestic callers and +1-212-231-2904 for international callers.
Analysts, investors and members of the media can access the live webcast via the Brooks website at https://brooks.investorroom.com/events. A replay will be available beginning at 8:30 a.m. ET on February 3, 2021.
Share this article
Share this article
SOUTH PLAINFIELD, N.J., Jan. 7, 2021 /PRNewswire/ Leading global genomics service provider, GENEWIZ, a Brooks Life Sciences Company, announced today that Alexandre Loupy, MD, Ph.D., Professor of Nephrology and Epidemiology at Necker Hospital, Paris, and Director of the Paris Transplant Group at Inserm, France, has been awarded the GENEWIZ Digital Spatial Profiler Grant. Dr. Loupy will be provided digital spatial profiling services on the NanoString Technologies® GeoMx™ platform for his study investigating the spatial immune response during allograft rejection.
The success or failure of organ transplantation largely depends on rejection responses. Rejection accounts for most allograft failures worldwide, with immediate effects on patient mortality, morbidity – presenting various complications for the patient health – and high societal costs. For nearly 30 years, the Banff Classification of Allograft Pathology has provided a unique di
Biobanking Market Size Will Grow at a CAGR of 7 6% By 2023 openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.